Aurora Cannabis (NYSE:ACB) announces that it completed its first commercial export of cannabis oil to the United Kingdom.
Specialist doctors in the U.K. can legally issue prescriptions for cannabis-based medicines when they agree that their patients could benefit from this treatment.
“Being one of the first Canadian companies to commercially supply cannabis-based medicines into the UK under the new legal framework reflects Aurora’s ability to do business in international markets that have complex and evolving regulatory systems,” says Aurora Chief Global Business Development Officer Neil Belot
ACB +0.40% premarket to $7.62.
Source: Press Release
Full story is available here.